US3093219A
(en)
|
1961-04-06 |
1963-06-11 |
Monte Copter Inc |
Plural-section airfoils
|
US3754368A
(en)
|
1969-11-04 |
1973-08-28 |
Moore Perk Corp |
Sterile packaging method
|
US4393871A
(en)
|
1977-06-27 |
1983-07-19 |
Vli Corporation |
Vaginal device
|
US4182827A
(en)
|
1978-08-31 |
1980-01-08 |
Union Carbide Corporation |
Polyurethane hydrogels having enhanced wetting rates
|
CH655656B
(ja)
|
1982-10-07 |
1986-05-15 |
|
|
US4822604A
(en)
|
1985-05-20 |
1989-04-18 |
S. C. Johnson & Son, Inc. |
Local treatment of dandruff, seborrheic dermatitis, and psoriasis
|
US4829092A
(en)
|
1987-07-27 |
1989-05-09 |
Chesebrough-Pond's Inc. |
Glycerol and diglycerol mixtures for skin moisturizing
|
MX21453A
(es)
|
1989-07-07 |
1994-01-31 |
Ciba Geigy Ag |
Preparaciones farmaceuticas que se administran en forma topica.
|
US6017521A
(en)
|
1989-10-31 |
2000-01-25 |
Columbia Laboratories, Inc. |
Use of polycarboxylic acid polymers to treat vaginal infections
|
GB9125712D0
(en)
|
1991-12-03 |
1992-01-29 |
Smithkline Beecham Plc |
Skin care composition
|
US5814666A
(en)
|
1992-04-13 |
1998-09-29 |
The United States As Represented By The Department Of Health And Human Services |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
US5632981A
(en)
|
1992-08-24 |
1997-05-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
US5910316A
(en)
|
1992-08-24 |
1999-06-08 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Use of nitric oxide-releasing agents to treat impotency
|
US5405919A
(en)
|
1992-08-24 |
1995-04-11 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
|
US5691423A
(en)
|
1992-08-24 |
1997-11-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polysaccharide-bound nitric oxide-nucleophile adducts
|
JPH08502490A
(ja)
|
1992-10-16 |
1996-03-19 |
スミスクライン・ビーチャム・コーポレイション |
組成物
|
JP3739100B2
(ja)
|
1993-07-30 |
2006-01-25 |
救急薬品工業株式会社 |
低温架橋型ゲル剤
|
US5840759A
(en)
|
1993-10-08 |
1998-11-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
|
US6709681B2
(en)
|
1995-02-17 |
2004-03-23 |
Aberdeen University |
Acidified nitrite as an antimicrobial agent
|
GB9804469D0
(en)
|
1998-03-02 |
1998-04-29 |
Univ Aberdeen |
Antiviral composition
|
US5519020A
(en)
|
1994-10-28 |
1996-05-21 |
The University Of Akron |
Polymeric wound healing accelerators
|
DE19512181C2
(de)
|
1995-03-31 |
2003-11-06 |
Hexal Pharma Gmbh |
Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
|
US5714511A
(en)
|
1995-07-31 |
1998-02-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
|
US5968001A
(en)
|
1996-05-14 |
1999-10-19 |
Bristol-Myers Squibb Company |
Wound dressings with leak prevention seal
|
US5770645A
(en)
|
1996-08-02 |
1998-06-23 |
Duke University Medical Center |
Polymers for delivering nitric oxide in vivo
|
US5958427A
(en)
|
1996-11-08 |
1999-09-28 |
Salzman; Andrew L. |
Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
|
US5968528A
(en)
|
1997-05-23 |
1999-10-19 |
The Procter & Gamble Company |
Skin care compositions
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
US20020013304A1
(en)
|
1997-10-28 |
2002-01-31 |
Wilson Leland F. |
As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
|
IL136042A
(en)
|
1997-11-10 |
2005-12-18 |
Cellegy Pharma Inc |
Alcohol-containing composition for topical application
|
US6103266A
(en)
|
1998-04-22 |
2000-08-15 |
Tapolsky; Gilles H. |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
|
US6103275A
(en)
|
1998-06-10 |
2000-08-15 |
Nitric Oxide Solutions |
Systems and methods for topical treatment with nitric oxide
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
US6818018B1
(en)
|
1998-08-14 |
2004-11-16 |
Incept Llc |
In situ polymerizable hydrogels
|
US20040043068A1
(en)
|
1998-09-29 |
2004-03-04 |
Eugene Tedeschi |
Uses for medical devices having a lubricious, nitric oxide-releasing coating
|
WO2000022207A2
(en)
|
1998-10-01 |
2000-04-20 |
The University Of Akron |
Process and apparatus for the production of nanofibers
|
WO2000049993A2
(en)
|
1999-02-24 |
2000-08-31 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
GB2354441A
(en)
|
1999-08-06 |
2001-03-28 |
Mccormack Ltd |
Composition for treating dentine hypersensitivity
|
US6479058B1
(en)
|
1999-09-02 |
2002-11-12 |
Mccadden Michael E. |
Composition for the topical treatment of poison ivy and other forms of contact dermatitis
|
DE19945484A1
(de)
*
|
1999-09-22 |
2001-04-05 |
Kolb Bachofen Victoria |
NO-freisetzende topisch applizierbare Zusammensetzung
|
US6737447B1
(en)
|
1999-10-08 |
2004-05-18 |
The University Of Akron |
Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
|
US6719997B2
(en)
|
2000-06-30 |
2004-04-13 |
Dermatrends, Inc. |
Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
|
US6627301B2
(en)
|
2000-03-28 |
2003-09-30 |
Showa Denko Kabushiki Kaisha |
Magnetic recording medium
|
US6762202B2
(en)
|
2000-05-09 |
2004-07-13 |
Nitromed, Inc. |
Infrared thermography and methods of use
|
US6475500B2
(en)
|
2000-07-10 |
2002-11-05 |
The Procter & Gamble Company |
Anhydrous cosmetic compositions
|
HUP0002628A2
(en)
|
2000-07-14 |
2002-06-29 |
Keri Pharma Kft |
Pharmaceutical combinations for treating diabetes
|
WO2002016934A1
(en)
|
2000-08-25 |
2002-02-28 |
Queen Mary & Westfield College |
Assay for s-nitrosothiol compounds
|
GB0022084D0
(en)
|
2000-09-08 |
2000-10-25 |
Univ Aberdeen |
Treatment of multiply antibiotic-resistant organisms
|
US20020122771A1
(en)
|
2000-09-23 |
2002-09-05 |
Troy Holland |
Spray hydrogel wound dressings
|
WO2002041902A1
(en)
|
2000-11-27 |
2002-05-30 |
The University Of Akron |
Treatment of disorders using polyethylenimine diazeniumdiolate
|
US7060732B2
(en)
|
2000-12-12 |
2006-06-13 |
Imaginative Research Associates, Inc. |
Antibiotic/benzoyl peroxide dispenser
|
US6780849B2
(en)
|
2000-12-21 |
2004-08-24 |
Scimed Life Systems, Inc. |
Lipid-based nitric oxide donors
|
US20040009238A1
(en)
|
2002-07-09 |
2004-01-15 |
Chris Miller |
Exogenenous nitric oxide gas (gNO) therapy in wound healing
|
US6706274B2
(en)
|
2001-01-18 |
2004-03-16 |
Scimed Life Systems, Inc. |
Differential delivery of nitric oxide
|
GB0119011D0
(en)
|
2001-08-03 |
2001-09-26 |
Univ Aberdeen |
Treatment of nail infections
|
US6520425B1
(en)
|
2001-08-21 |
2003-02-18 |
The University Of Akron |
Process and apparatus for the production of nanofibers
|
US6703046B2
(en)
|
2001-10-04 |
2004-03-09 |
Medtronic Ave Inc. |
Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
|
US6846846B2
(en)
|
2001-10-23 |
2005-01-25 |
The Trustees Of Columbia University In The City Of New York |
Gentle-acting skin disinfectants
|
US6765001B2
(en)
|
2001-12-21 |
2004-07-20 |
Medicis Pharmaceutical Corporation |
Compositions and methods for enhancing corticosteroid delivery
|
JP2003212773A
(ja)
|
2002-01-04 |
2003-07-30 |
Oramon Arzneimittel Gmbh |
セチリジン及びロラタジンの局所医薬組成物
|
EP1542556B1
(en)
|
2002-01-08 |
2011-09-21 |
Bernard Technologies, Inc. |
Antimicrobial body covering articles
|
US20030159702A1
(en)
|
2002-01-21 |
2003-08-28 |
Lindell Katarina E.A. |
Formulation and use manufacture thereof
|
US6695992B2
(en)
|
2002-01-22 |
2004-02-24 |
The University Of Akron |
Process and apparatus for the production of nanofibers
|
JP2003286153A
(ja)
|
2002-01-24 |
2003-10-07 |
Shiseido Co Ltd |
皮膚外用組成物
|
JP4229842B2
(ja)
|
2002-02-22 |
2009-02-25 |
ルバンス セラピュティックス インク. |
L−アルギニンオリゴマーを含む化粧品処方
|
US20030175328A1
(en)
|
2002-03-06 |
2003-09-18 |
Adi Shefer |
Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
|
ATE417610T1
(de)
|
2002-03-12 |
2009-01-15 |
Galderma Res & Dev |
Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
|
EP1495026A4
(en)
|
2002-03-20 |
2008-07-09 |
Univ Queensland |
METHODS AND COMPOSITIONS CONTAINING NITRIC OXIDE DONORS AND OPIOID ANALGESICS
|
CA2480832A1
(en)
|
2002-04-05 |
2003-10-23 |
Nitromed, Inc. |
Nitric oxide donors, compositions and methods of use
|
EP1501563A1
(en)
|
2002-05-03 |
2005-02-02 |
Duke University Medical Center |
Carbon nanotubules for storage of nitric oxide
|
US7328706B2
(en)
|
2002-05-06 |
2008-02-12 |
Dynamic Mouth Devices Llc |
Therapeutic and protective dental device useful as an intra-oral delivery system
|
CA2485167A1
(en)
|
2002-05-07 |
2003-11-20 |
The Government Of The United States Of America |
Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
|
JP4634144B2
(ja)
|
2002-08-01 |
2011-02-16 |
ニコックス エスエー |
ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
|
WO2004012874A1
(en)
|
2002-08-02 |
2004-02-12 |
The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services |
Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US20050271596A1
(en)
|
2002-10-25 |
2005-12-08 |
Foamix Ltd. |
Vasoactive kit and composition and uses thereof
|
US20070292359A1
(en)
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US20080317679A1
(en)
|
2002-10-25 |
2008-12-25 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US20080206161A1
(en)
|
2002-10-25 |
2008-08-28 |
Dov Tamarkin |
Quiescent foamable compositions, steroids, kits and uses thereof
|
US20080031907A1
(en)
|
2002-10-25 |
2008-02-07 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam
|
US20070292461A1
(en)
|
2003-08-04 |
2007-12-20 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
FR2850579B1
(fr)
|
2003-02-03 |
2006-08-18 |
Oreal |
Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
|
EP1603933A2
(en)
|
2003-03-13 |
2005-12-14 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds, compositions and methods of use
|
US20040202684A1
(en)
|
2003-04-08 |
2004-10-14 |
David Djerassi |
Personalized interactive natural cosmetics
|
KR101187231B1
(ko)
|
2003-04-24 |
2012-10-02 |
갈데르마 소시에떼아노님 |
피부과 질병 치료용 이버멕틴의 외용 제형물
|
US7879357B2
(en)
|
2003-04-28 |
2011-02-01 |
Bayer Schering Pharma Ag |
Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
|
EP1491188A1
(en)
|
2003-06-25 |
2004-12-29 |
G2M Cancer Drugs AG |
Topical use of valproic acid for the prevention or treatment of skin disorders
|
US7972137B2
(en)
|
2003-06-30 |
2011-07-05 |
Rosen Gerald M |
Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
|
ES2645566T3
(es)
|
2003-07-03 |
2017-12-05 |
The University Court Of The University Of St Andrews |
Zeolitas para el suministro de óxido nítrico
|
US20050038473A1
(en)
|
2003-07-14 |
2005-02-17 |
Dov Tamarkin |
Device and method for the treatment of pilosebaceous disorders
|
WO2005011575A2
(en)
|
2003-07-25 |
2005-02-10 |
The University Of Akron |
Stabilization and ionic triggering of nitric oxide release
|
US20080069779A1
(en)
|
2003-08-04 |
2008-03-20 |
Foamix Ltd. |
Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
|
CA2534372C
(en)
*
|
2003-08-04 |
2012-01-24 |
Foamix Ltd. |
Foam carrier containing amphiphilic copolymeric gelling agent
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
WO2005037339A1
(en)
|
2003-10-14 |
2005-04-28 |
Cube Medical A/S |
A balloon for use in angioplasty
|
GB0326047D0
(en)
|
2003-11-07 |
2003-12-10 |
Univ Sheffield |
Substance
|
US8017074B2
(en)
|
2004-01-07 |
2011-09-13 |
Noxilizer, Inc. |
Sterilization system and device
|
CA2556993C
(en)
|
2004-04-08 |
2013-05-21 |
Novartis Ag |
Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
|
JP2007532697A
(ja)
|
2004-04-19 |
2007-11-15 |
ストラテジック サイエンス アンド テクノロジーズ, エルエルシー |
局所的血流増大の有益な効果
|
US20070166255A1
(en)
|
2004-11-22 |
2007-07-19 |
Gupta Shyam K |
Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition
|
WO2006058318A2
(en)
*
|
2004-11-29 |
2006-06-01 |
The University Of Akron |
Topical nitric oxide donor devices
|
WO2006073767A1
(en)
|
2005-01-04 |
2006-07-13 |
Teikoku Pharma Usa, Inc. |
Cooling topical patch preparation
|
CA2594407C
(en)
|
2005-02-11 |
2014-06-10 |
Nolabs Ab |
Device method, and use for treatment of neuropathy involving nitric oxide
|
EP1757278A1
(en)
|
2005-08-23 |
2007-02-28 |
NOLabs AB |
Device, system, and method comprising microencapsulated liquid for release of nitric oxide from a polymer
|
EP1707224A1
(en)
|
2005-02-11 |
2006-10-04 |
NOLabs AB |
Pharmaceutical mixture with nitric oxide booster, device for applying the mixture and manufacturing method therefor
|
PT1861130E
(pt)
|
2005-02-11 |
2008-12-02 |
Nolabs Ab |
Dispositivo e método para o tratamento de dermatomicose, e em particular de onicomicose
|
US20080171795A1
(en)
|
2005-03-21 |
2008-07-17 |
Life-Care Innovations Pvt. Ltd. |
Novel Inter and Intra Multilamellar Vesicular Composition
|
WO2006100154A1
(en)
|
2005-03-24 |
2006-09-28 |
Nolabs Ab |
Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
|
EP1704876A1
(en)
|
2005-03-24 |
2006-09-27 |
NOLabs AB |
Cosmetic treatment, device for performing said treatment and manufacturing method thereof
|
BRPI0612428A2
(pt)
|
2005-05-09 |
2010-11-09 |
Foamix Ltd |
composição farmacêutica higroscópica, veìculo farmacêutico espumoso e composição farmacêutica espumosa
|
FR2885527B1
(fr)
|
2005-05-16 |
2007-06-29 |
Galderma Res & Dev |
Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
|
CA2606565C
(en)
|
2005-05-27 |
2016-05-10 |
The University Of North Carolina At Chapel Hill |
Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
|
WO2006138035A1
(en)
|
2005-06-13 |
2006-12-28 |
Dow Corning Corporation |
Vehicle for the delivery of topical lipid soluble pharmaceutical agents
|
US20080152596A1
(en)
|
2005-07-19 |
2008-06-26 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
WO2007092312A2
(en)
|
2006-02-03 |
2007-08-16 |
Stiefel Laboratories, Inc. |
Topical skin treating compositions
|
US7744928B2
(en)
*
|
2006-04-14 |
2010-06-29 |
Advanced Cardiovascular Systems, Inc. |
Methods and compositions for treatment of lesioned sites of body vessels
|
WO2008038140A2
(en)
|
2006-06-07 |
2008-04-03 |
Foamix Ltd. |
Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
|
US8333997B2
(en)
|
2006-06-21 |
2012-12-18 |
Albert Einstein College Of Medicine Of Yeshiva University |
Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
|
WO2008110872A2
(en)
|
2006-06-23 |
2008-09-18 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
EP2494959B1
(en)
|
2006-07-05 |
2014-11-19 |
Foamix Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
GB0616350D0
(en)
|
2006-08-17 |
2006-09-27 |
Univ St Andrews |
Adsorption and release of nitric oxide in metal organic frameworks
|
BRPI0714754A2
(pt)
|
2006-09-08 |
2013-05-14 |
Foamix Ltd |
composiÇço tàpica colorida ou colorÍvel, mÉtodo para a mudanÇa de cor de uma composiÇço tàpica colorida ou colorÍvel e kit para aplicaÇço tàpica
|
EP1923041A1
(de)
|
2006-10-20 |
2008-05-21 |
Symrise GmbH & Co. KG |
Verwendung von C10-C14-Alkandiolen zur Herstellung eines Mittels zur Prophylaxe und/oder Behandlung von Malassezia-induzierter Schuppenbildung, sowie Zubereitungen enthaltend C10-C14-Alkandiole
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
EP2073794A2
(en)
|
2006-11-14 |
2009-07-01 |
Foamix Ltd. |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
WO2008152444A2
(en)
|
2006-11-29 |
2008-12-18 |
Foamix Ltd. |
Foamable waterless compositions with modulating agents
|
FR2910320B1
(fr)
|
2006-12-21 |
2009-02-13 |
Galderma Res & Dev S N C Snc |
Emulsion comprenant au moins un retinoide et du peroxyde de benzole
|
US20080292560A1
(en)
|
2007-01-12 |
2008-11-27 |
Dov Tamarkin |
Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
|
US8530436B2
(en)
|
2007-01-29 |
2013-09-10 |
Transderm, Inc. |
Methods and compositions for transdermal delivery of nucleotides
|
RU2009139781A
(ru)
|
2007-03-27 |
2011-05-10 |
Нолабс Аб (Se) |
Устройство для доставки оксида азота для местного воздействия на кожу
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
US8617100B2
(en)
|
2007-09-04 |
2013-12-31 |
Foamix Ltd. |
Device for delivery of a foamable composition
|
WO2009049208A1
(en)
|
2007-10-12 |
2009-04-16 |
The University Of North Carolina At Chapel Hill |
Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
|
EP2219600A4
(en)
|
2007-11-19 |
2012-09-12 |
Stiefel Laboratories |
TOPICAL COSMETIC SKIN COMPOSITIONS AND APPLICATION METHOD THEREFOR
|
US20090130029A1
(en)
|
2007-11-21 |
2009-05-21 |
Foamix Ltd. |
Glycerol ethers vehicle and pharmaceutical compositions thereof
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
WO2009090495A2
(en)
|
2007-12-07 |
2009-07-23 |
Foamix Ltd. |
Oil and liquid silicone foamable carriers and formulations
|
US8557911B2
(en)
|
2007-12-27 |
2013-10-15 |
Eastman Kodak Company |
Aqueous colloidal dispersions stabilized with polymeric dispersants
|
CA2711703A1
(en)
|
2008-01-08 |
2009-07-16 |
Foamix Ltd. |
Sensation modifying topical composition foam
|
FR2929278A1
(fr)
|
2008-04-01 |
2009-10-02 |
Centre Nat Rech Scient |
Solide hybride cristallin poreux pour l'adsorption et la liberation de gaz a interet biologique.
|
WO2009131931A1
(en)
*
|
2008-04-21 |
2009-10-29 |
3M Innovative Properties Company |
Nitric oxide-releasing compositions, devices and methods
|
US20120141384A1
(en)
|
2008-05-06 |
2012-06-07 |
Dov Tamarkin |
Antibacterial conjugated boronic acids and pharmaceutical compositions thereof
|
KR101199580B1
(ko)
|
2008-08-06 |
2013-11-27 |
(주)에델프라우 |
국소 투여용 나노에멀젼
|
EP2334279A4
(en)
|
2008-10-16 |
2013-03-20 |
Novan Inc |
STAIN OXIDE RELEASING PARTICLES FOR MOUTH CARE APPLICATIONS
|
CA2766120C
(en)
|
2009-07-07 |
2018-08-14 |
Convatec Technologies Inc. |
Amphiphilic silicone copolymers for pressure sensitive adhesive applications
|
ES2958410T3
(es)
*
|
2009-08-21 |
2024-02-08 |
Novan Inc |
Geles tópicos
|
BR112012003804B1
(pt)
|
2009-08-21 |
2019-02-19 |
Novan, Inc. |
Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
|
TR201203732T1
(tr)
|
2009-10-01 |
2012-09-21 |
Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. |
Opioid antagonistlerin topikal bileşimleri ve deri hastalıklarının bu bileşimler ile tedavisi için yöntemler.
|
BR112012008508A2
(pt)
|
2009-10-13 |
2017-06-13 |
Novan Inc |
revestimento de sol-gel, substrato, método para produzir um revestimento de sol-gel
|
WO2011061519A2
(en)
|
2009-11-23 |
2011-05-26 |
Cipla Limited |
Topical foam composition
|
JP2013514347A
(ja)
|
2009-12-16 |
2013-04-25 |
シャスン ファーマシューティカルズ リミテッド |
デクスイブプロフェン経皮ヒドロゲルの組成物
|
WO2011085484A1
(en)
|
2010-01-13 |
2011-07-21 |
Nitric Solutions Inc. |
Antimicrobial nitric oxide compositions
|
CN101791411B
(zh)
|
2010-01-25 |
2012-05-23 |
中国药科大学 |
两亲性多糖偶联物及其药物组合物的制备和应用
|
CN101732728B
(zh)
|
2010-01-25 |
2012-11-14 |
中国药科大学 |
抗炎药物-多糖偶联物及其药物组合物的制备和应用
|
US20120064013A1
(en)
|
2010-02-03 |
2012-03-15 |
David Marcos |
Foamable topical composition
|
AU2011243947A1
(en)
|
2010-04-23 |
2012-12-06 |
Piramal Enterprises Limited |
Nitric oxide releasing prodrugs of therapeutic agents
|
EP2387990A1
(en)
|
2010-05-06 |
2011-11-23 |
Skinius S.R.L. |
Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
|
GB201010954D0
(en)
|
2010-06-29 |
2010-08-11 |
Edko Pazarlama Tanitim Ticaret |
Compositions
|
EA015747B1
(ru)
|
2010-07-08 |
2011-10-31 |
Общество С Ограниченной Ответственностью "Вдс" |
Состав для профилактики кандидозов
|
JP2013538188A
(ja)
|
2010-07-14 |
2013-10-10 |
ダウ コーニング コーポレーション |
シリコーンゲルを用いる2種薬物送達
|
US8591876B2
(en)
*
|
2010-12-15 |
2013-11-26 |
Novan, Inc. |
Methods of decreasing sebum production in the skin
|
CN102100663B
(zh)
|
2011-01-14 |
2013-04-17 |
华南理工大学 |
一种pH敏感型原位凝胶纳米缓释眼药水的制备方法
|
EP2665763B1
(en)
|
2011-01-20 |
2015-08-26 |
Novan, Inc. |
Temperature controlled sol-gel co-condensation
|
WO2012118829A2
(en)
|
2011-02-28 |
2012-09-07 |
Novan, Inc. |
Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
|
JP2014508166A
(ja)
*
|
2011-03-17 |
2014-04-03 |
トランスダーマル バイオテクノロジ インコーポレーテッド |
局所的一酸化窒素システム及びその使用方法
|
WO2012153331A2
(en)
|
2011-05-09 |
2012-11-15 |
Topical Therapeutic Agent (Tta) Ltd. |
Nitric oxide-sequestering topical formulations
|
WO2013006613A1
(en)
|
2011-07-05 |
2013-01-10 |
Novan, Inc. |
Methods of manufacturing topical compositions and apparatus for same
|
EP2729131B1
(en)
|
2011-07-05 |
2020-04-15 |
Novan, Inc. |
Topical compositions
|
ES2658897T3
(es)
|
2011-08-24 |
2018-03-12 |
Novan, Inc. |
Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
|
WO2013063354A1
(en)
|
2011-10-27 |
2013-05-02 |
Novan, Inc. |
Nitric oxide releasing bath compositions and methods of using the same
|
WO2013138073A1
(en)
|
2012-03-13 |
2013-09-19 |
Novan, Inc. |
Methods of modulating steroid hormone activity
|
US11077194B2
(en)
|
2012-03-14 |
2021-08-03 |
Novan, Inc. |
Nitric oxide releasing pharmaceutical compositions
|
AU2013259166B2
(en)
|
2012-05-11 |
2016-03-10 |
Theragenics Corporation |
Biocompatible hydrogel treatments for retinal detachment
|
US9540471B2
(en)
|
2012-07-17 |
2017-01-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitric oxide-releasing diazeniumdiolated polyvinylpyrrolidone-based polymers, and compositions, medical devices, and uses thereof
|
WO2014028847A1
(en)
|
2012-08-17 |
2014-02-20 |
The University Of North Carolina At Chapel Hill |
Water soluble nitric oxide-releasing polyglucosamines and uses thereof
|
US9187501B2
(en)
|
2012-08-28 |
2015-11-17 |
The University Of North Carolina At Chapel Hill |
Nitric oxide-releasing nanorods and their methods of use
|
US9855211B2
(en)
|
2013-02-28 |
2018-01-02 |
Novan, Inc. |
Topical compositions and methods of using the same
|
CN105142600A
(zh)
|
2013-03-15 |
2015-12-09 |
前沿创新有限公司 |
包含高水平水混溶性溶剂之疏水剂的基本上不含表面活性剂的亚微米分散体
|
US10206947B2
(en)
|
2013-08-08 |
2019-02-19 |
Novan, Inc. |
Topical compositions and methods of using the same
|
BR112016002387B1
(pt)
|
2013-08-08 |
2019-05-21 |
Novan, Inc. |
Composições farmacêuticas tópicas, e método para seu armazenamento
|
US20150259283A1
(en)
|
2014-03-13 |
2015-09-17 |
Brickell Biotech, Inc. |
Formulation for soft anticholinergic analogs
|
BR112017000456B1
(pt)
|
2014-07-11 |
2022-12-13 |
Novan, Inc |
Uso de um ingrediente farmacêutico ativo de liberação de óxido nítrico e composição tópica para tratamento e/ou prevenção de uma infecção viral
|
US10322082B2
(en)
|
2014-07-11 |
2019-06-18 |
Novan, Inc. |
Topical antiviral compositions and methods of using the same
|
WO2016010988A1
(en)
|
2014-07-14 |
2016-01-21 |
Novan, Inc. |
Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
|
AU2016297601B2
(en)
|
2015-07-21 |
2021-08-19 |
Bodor Laboratories, Inc. |
Formulation for soft anticholinergic analogs
|
WO2017030555A1
(en)
|
2015-08-17 |
2017-02-23 |
Bhalani Vinayak T |
Topical film delivery system
|
KR102319497B1
(ko)
|
2016-03-02 |
2021-11-01 |
노반, 인크. |
염증 치료용 조성물 및 염증 치료 방법
|
AR108116A1
(es)
|
2016-04-11 |
2018-07-18 |
Biolab Sanus Farmaceutica Ltda |
Composición dermocosmética, proceso de producción de la composición tópica, método para fortalecimiento de uñas frágiles y uso de la composición
|
CN116585257A
(zh)
|
2016-04-13 |
2023-08-15 |
诺万公司 |
用于治疗感染的组合物、系统、试剂盒和方法
|
TWI719046B
(zh)
|
2016-07-21 |
2021-02-21 |
美商波德實驗股份有限公司 |
軟性抗膽鹼類似物之製劑
|
US10668002B2
(en)
|
2018-01-18 |
2020-06-02 |
Regenesis Group |
Anhydrous polysaccharide films
|
JP2021515807A
(ja)
|
2018-03-01 |
2021-06-24 |
ノーバン,インク. |
一酸化窒素放出性坐剤及びその使用の方法
|
SG11202111168UA
(en)
|
2019-04-09 |
2021-11-29 |
Dermbiont Inc |
Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
|
JP2023510662A
(ja)
|
2019-06-04 |
2023-03-15 |
サーティー レスピラトリー リミテッド |
窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
|
US11419809B2
(en)
|
2019-06-27 |
2022-08-23 |
L'oreal |
Hair treatment compositions and methods for treating hair
|
JP2022545370A
(ja)
|
2019-08-14 |
2022-10-27 |
ナノメティクス エルエルシー (ディー.ビー.エー ピーエイチディー バイオサイエンシズ) |
ウラシル皮膚医薬製剤
|
CA3174550A1
(en)
|
2020-03-03 |
2021-09-10 |
Kaken Pharmaceutical Co., Ltd. |
Medicament containing sofpironium bromide
|
JP2023529356A
(ja)
|
2020-06-02 |
2023-07-10 |
シンガポール国立大学 |
組成物、治療におけるそれらの使用およびその方法
|
CA3190833A1
(en)
|
2020-08-26 |
2022-03-03 |
Michael Mcdonald CROWLEY |
Compositions, devices and methods for treating nasal, otic and other tissue infection and/or inflammation
|
CN112402615A
(zh)
|
2020-11-11 |
2021-02-26 |
长沙晶易医药科技有限公司 |
一种用于治疗斑秃的复方外用制剂及其制备方法
|
AU2022222528A1
(en)
|
2021-02-18 |
2023-08-24 |
Lyrus Life Sciences Pvt Ltd |
Novel arthritis emulgel composition and its preparation process
|